Human Catalase Gene is Regulated by Peroxisome Proliferator Activated Receptor-gamma through a Response Element Distinct from That of Mouse
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oxidative stress has been implicated as a causal role in atherosclerosis, microvascular complications of diabetes as well as in beta cell failure in type 2 diabetes. PPARgamma agonists not only improve insulin sensitivity but also eliminate oxidative stress. In mouse, catalase, a major antioxidant enzyme, is directly regulated by PPARgamma through two PPARgamma binding elements in its promoter. This study examined the regulatory mechanisms of catalase expression in human. Expression of catalase was significantly upregulated in human primary adipocytes upon treatment with a PPARgamma agonist. However, the mouse PPARgamma response elements are not functionally conserved in human catalase promoter. In luciferase reporter assay containing human catalase promoter, PPARgamma /RXRalpha, in combination of a PPARgamma agonist significantly transactivated 19 kb of promoter and this was mediated via a novel PPARgamma response element (PPRE) at -12 kb from transcription initiation site of human catalase gene. Electrophoretic mobility shift assay showed direct binding of PPARgamma to this PPRE. Together, our results indicate that PPARgamma regulates the expression of catalase gene in human through a PPRE distinct from that of mouse, and could explain, at least in part, the observed inhibitory effects of PPARgamma on oxidative stress in human.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Self-citationThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“In rodents, PPARγ agonists, which are clinically used for treatment of diabetes, can eliminate oxidative stress both in vitro [3] and in vivo [4, 5], and also increase the expression of catalase, a major antioxidant which converts hydrogen peroxide to oxygen and water [6, 7].”
BackgroundCarroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · cited 1×
“White or black arrow indicates the shifted band of the labeled oligonucleotide bound to PPARγ or PPARγ/ antibody complex, respectively. references 1. robertson rP (2004) chronic oxidative stress as a cen- tral mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.”
BackgroundRemote control of gene transcription
West, A. G., & Fraser, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi104 · Cited by 302
Cited by
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Matsuda, M., & Shimomura, I. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.05.004 · Cited by 641
Self-citationSelf-regulation of the inflammatory response by peroxisome proliferator-activated receptors
Korbecki, J., Bobiński, R., & Dutka, M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01231-1 · Cited by 415
Regulation of catalase expression in healthy and cancerous cells
Glorieux, C., Zamocky, M., Sandoval, J. M., Verrax, J., & Calderon, P. B. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.017 · Cited by 256
PPAR and Oxidative Stress: Con() Catenating NRF2 and FOXO
Polvani, S., Tarocchi, M., & Galli, A. (2012) · PPAR Research · doi:10.1155/2012/641087 · Cited by 245
“The mouse, human, and rat catalase [45, 46], a major antioxidant enzyme that decomposes H2O2 to H2O and O2, is transcriptional regulated by PPARγ through PPREs containing the canonical DR-1 [46] and that may be located as far as 12 kb from the transcription initiation site [45].”
BackgroundBrowsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer
Galasso, M., Gambino, S., Romanelli, M. G., Donadelli, M., & Scupoli, M. T. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.010 · Cited by 183
Human Catalase, Its Polymorphisms, Regulation and Changes of Its Activity in Different Diseases
Kodydková, J., Vávrová, L., Kocík, M., & Žák, A. (2014) · Folia Biologica · doi:10.14712/fb2014060040153 · Cited by 158
“PPARγ is a ligand-activated transcription factor that controls expression of the CAT gene by binding to a dis tal PPARγ response element (PPRE) in its promoter re gion (Okuno et al., 2010; yang et al., 2011).”
BackgroundOkuno, Y., Fukuhara, A., Hashimoto, E., Kobayashi, H., Kobayashi, S., Otsuki, M., & Shimomura, I. (2018) · Diabetes · doi:10.2337/db17-1032 · Cited by 124
Kovacs, D., Flori, E., Maresca, V., Ottaviani, M., Aspite, N., Dell'Anna, M. L., Panzella, L., Napolitano, A., Picardo, M., & d'Ischia, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.457 · Cited by 50
Metadata
- Authors
- OKUNO, Y., MATSUDA, M., MIYATA, Y., FUKUHARA, A., KOMURO, R., SHIMABUKURO, M., & SHIMOMURA, I.
- Venue
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Published
- 2010
- Volume
- 57
- Issue
- 4
- Pages
- 303-309
- ISSN
- 0918-8959 (ISSN-L)
- 1348-4540
- OpenAlex
- W2062778001
- Cited by
- 112
- References
- 7
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.